Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Expert Opinion on Drug Metabolism & Toxicology|February 25, 2009
Computational approaches to predict drug metabolismPaul Czodrowski, Jan M Kriegl, Stefan Scheuerer, et al.Bioorganic & Medicinal Chemistry Letters|August 30, 2011
Discovery of BI 99179, a potent and selective inhibitor of type I fatty acid synthase with central exposureJörg T Kley, Jürgen Mack, Bradford Hamilton, et al.The Journal of Pharmacology and Experimental Therapeutics|March 2, 2021
An Integrative Approach for Improved Assessment of Cardiovascular Safety DataMikael Wallman, Stefan Scheuerer, Eric Martel, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 25, 2017
Modeling energy intake and body weight effects of a long-acting amylin analogueAnnika Brings, Jens Markus Borghardt, Jolanta Skarbaliene, et al.Drug Discovery Today|November 9, 2024
Beyond CL and VSS: A comprehensive approach to human pharmacokinetic predictionsAnneke Himstedt, Hermann Rapp, Peter Stopfer, et al.Psychopharmacology|July 4, 2019
NMDA receptor antagonists traxoprodil and lanicemine improve hippocampal-prefrontal coupling and reward-related networks in ratsRobert Becker, Natalia Gass, Lothar Kußmaul, et al.Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Novel 6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohepta[f]indene analogues as potent and selective 5-HT(2C) agonists for the treatment of metabolic disordersHeather Tye, Stephan G Mueller, Juergen Prestle, et al.ACS Chemical Neuroscience|February 5, 2025
Further Optimization of the mGlu1 PAM VU6024578/BI02982816: Discovery and Characterization of VU6033685Carson W Reed, Jacob F Kalbfleisch, Jeremy A Turkett, et al.Pageof 1